Prostate News Archive
01-Oct-2006
Risk of prostate cancer needs to be addressed (Philadelphia Tribune)
Men, now is the time to get serious about our health by simply getting it checked. An annual health exam can save your life and, most of all, provide opportunities for healthier living. Long-Term Outcomes For Prostate Cancer Show IMRT Curative: 89 Percent Disease-free 8 Years Later (Medical News Today)
Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years. The 561 prostate cancer patients treated with IMRT at Memorial Sloan-Kettering Cancer Center were classified into prognostic risk groups. [click Prostate?s top 10 (The Star Online)
Consultant oncologist Dr G. SELVARATNAM looks at the top 10 questions asked by men about prostate cancer. Long-term Outcomes For Prostate Cancer Show Intensity Modulated Radiation Therapy Curative (Science Daily)
Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years. Good Outcome for Prostate Radiation (RedNova)
U.S. prostate-cancer patients treated with high-dose, intensity modulated radiation therapy, or IMRT, results in most patients alive eight year later. Prostate cancer screening event was a success (The Kentucky Standard)
The University of Louisville Kentucky Cancer Program (KCP) is grateful to Nelson County-City of Bardstown for helping to make the recent free prostate cancer screening, Drive Across Kentucky, a huge success. The Relationship Of Ultrasensitive Measurements Of Prostate-specific Antigen Levels To Prostate Cancer Recurrence After (Medical News Today)
A rising PSA following radical prostatectomy (RP) for prostate cancer (CaP) suggests disease recurrence. Ultrasensitive PSA (USPSA) tests can detect PSA at values as low as 0.001ng/ml. Dr. Taylor and colleagues publish a report in the September 2006 issue of the BJU International that evaluates USPSA values in the context of clinical outcomes. [click link for full article] Acting against lung cancer (The Star Online)
IT?S a little-known fact that lung cancer is the leading cause of cancer deaths, globally. It claims more lives than colon, prostate, and breast cancer combined.
Back to Prostate News Archive
